| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |